Content section
Enforcement Watch
Enforcement Watch follows the decisions that show how healthcare rules are applied in practice. It connects individual ASA, GPhC, MHRA and CQC actions to the wider compliance pattern clinics need to understand.
-
MHRA: old patients are still the public
MHRA decisions show prescription-only medicine advertising risk across homepages, print, email, SMS and launch waitlists.
-
MHRA is investigating unlicensed Botox
The MHRA's Criminal Enforcement Unit is investigating unlicensed botulinum toxin products after a spike in hospital admissions. This enforcement analysis separates the authorised-product safety update from the criminal investigations.
-
GPhC finds weaknesses in weight-loss pharmacy safeguards
A GPhC review found weak risk assessments and inconsistent BMI checks in online pharmacies prescribing weight-loss medicines.
-
ASA upholds Black Friday Mounjaro ad complaints
The ASA ruled against Juniper and Voy over Black Friday promotions for prescription-only weight-loss medicines.
-
Most clinic ads are breaking this rule
Recent ASA rulings reveal a recurring pattern in weight-loss advertising for prescription-only medicines.
-
ASA caught 900 weight-loss ad violations in one sweep
The ASA's monitoring found roughly 900 prescription-only medicine advertising violations from 38 advertisers.